Call Options

5 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2024

May 14, 2024

SELL
$1.06 - $1.67 $151,474 - $238,643
-142,900 Reduced 99.37%
900 $1,000
Q1 2023

May 15, 2023

BUY
$1.2 - $2.19 $81,840 - $149,358
68,200 Added 90.21%
143,800 $191,000
Q4 2022

Feb 14, 2023

BUY
$1.63 - $3.52 $123,227 - $266,112
75,600 New
75,600 $127,000
Q1 2022

Jun 10, 2022

SELL
$2.83 - $8.69 $84,334 - $258,961
-29,800 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$8.31 - $14.92 $247,638 - $444,616
29,800 New
29,800 $248,000

Others Institutions Holding DNA

About Ginkgo Bioworks Holdings, Inc.


  • Ticker DNA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,287,779,968
  • Market Cap $489M
  • Description
  • Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...
More about DNA
Track This Portfolio

Track Skaana Management L.P. Portfolio

Follow Skaana Management L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Skaana Management L.P., based on Form 13F filings with the SEC.

News

Stay updated on Skaana Management L.P. with notifications on news.